Pharmaceutical companies are in deep trouble ahead of the end of generic drug price re-evaluation. As each pharmaceutical company announces drug price cuts for as many as 100 or more products, the atmosphere is concentrating on figuring out the size of the loss. Dissatisfaction with the government's indiscriminate re-evaluation of drug prices is also growing. According to the industry on the 21st, from September 5th, the insurance upper limit of 7,677 generic drugs will be cut by up to 27.75%. The drug price of 7677 items will be reduced by 15% and 256 items will be cut by 27.75%. As the generic drug price re-evaluation, which has been pursued for the past three years, has ended, drug price cuts are imminent. In June